Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposic vs Tears Naturale Forte in Dry Eye Syndrome
NCT03211351Completed
- Sponsor
- Huaxia Eye Hospital Group
- Start
- Jul 2017
- Primary completion
- Dec 2017
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial in dry eye syndrome (DED) comparing Liposic with Tears Naturale Forte (2 arms). Primary endpoints: Schirmer I test at 3 months, Corneal Fluorescein Staining at 3 months and 4 more. Started Jul 2017; status: completed.
02
Drugs
carbomerTears Naturale Forte
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT03211351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03211351.